Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride

Scientia Pharmaceutica

Volumn 78, Issue 2, 2010, Pages 303-323

  Singh, Bhupinder ^a   Rani, Ashu ^a   Babita, ^a   Ahuja, Naveen ^a   Kapil, Rishi ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Drug delivery; Experimental design; Floatation; Gastroretentive; Mucoadhesive

Indexed keywords

CARBOMER; CARBOPOL 971P; DOLFRE; EXCIPIENT; HYDROXYPROPYLMETHYLCELLULOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; TRAMADOL; TRAMAZAC; UNCLASSIFIED DRUG; XANTHAN;

ANIMAL TISSUE; ARTICLE; DRUG RELEASE; GRAVITY; HYDRODYNAMICS; MUCOADHESION; NONHUMAN; PHYSICAL CHEMISTRY; TABLET COMPRESSION; TABLET FORMULATION; TABLET PROPERTY;

EID: 77954630964     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1001-04     Document Type: Article

References (40)

1. Bomma R, Swamy Naidu RA, Yamsani MR, Veerabrahma K. Development and evaluation of gastroretentive norfloxacin floating tablets. Acta Pharm. 2009; 59: 211-221. doi:10.2478/v10007-009-0019-6
2. Peltola J, Coetzee C, Jimenez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. Epilepsia. 2009; 50: 406-414. doi:10.1111/j.1528-1167.2008.01817.x
3. Longer MA, Ching HS, Robinson JR. Bioadhesive polymers as platform for oral control drug delivery. III. Oral delivery of chlorthiazide using bioadhesive polymer. J Pharm Sci. 1985; 74: 406-410. doi:10.1002/jps.2600740408
4. Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000; 63: 235-259. doi:10.1016/S0168-3659(99)00204-7
5. Singh B, Pahuja S, Kapil R, Ahuja N. Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics. Acta Pharm. 2009; 59: 1-13. doi:10.2478/v10007-009-0005-z
6. Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol. 2006; 6: 501-508. doi:10.1016/j.coph.2006.04.007
7. Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv. 2006; 3: 217-233. doi:10.1517/17425247.3.2.217
8. Chitnis VS, Malshe VS, Lalla JK. Bioadhesive polymers-synthesis, evaluation and application in controlled release tablets. Drug Dev Ind Pharm. 1991; 17: 879-892. doi:10.3109/03639049109040824
9. Chueh HR, Zia H, Rhodes CT. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev Ind Pharm. 1995; 21: 1725-1747. doi:10.3109/03639049509069261
10. Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using Design of Experiments Part 1: Fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005; 22: 27-106. doi:10.1615/CritRevTherDrugCarrierSyst.v22.i1.20
11. Singh B, Dahiya M, Saharan V, Ahuja N. Optimizing drug delivery systems using Design of Experiments Part II: Retrospect and Prospects. Crit Rev Ther Drug Carrier Syst. 2005; 22: 215-292. doi:10.1615/CritRevTherDrugCarrierSyst.v22.i3.10
12. Singh B, Chakkal SK, Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech. 2006; 7: E1-E10. doi:10.1208/pt070103
13. Singh B, Ahuja N. Response surface optimization of drug delivery systems. In: Jain NK. (ed.). Progress in Controlled and Novel Drug Delivery Systems. 1st edn. CBS Publishers, New Delhi. 470-509, 2004.
14. Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare OP. Design, development and optimization of nimesulide-loaded loiposomal systems for topical application. Curr Drug Del. 2005; 2: 143-153. doi:10.2174/1567201053585985
15. USP. USP 30, NF 25. The United States Pharmacopeia and The National Formulary, The United States Pharmacopoeial Convention, INC., 12601 Twinbrook Parkway, Rockwille, MD 20852. ISSN: 0195-7996, ISBN: 1-889788-48-1. 2007.
16. Singh B, Singh S. A comprehensive computer program for study of drug release kinetics from compressed matrices. Indian J Pharm Sci. 1998; 60: 358-362.
17. Singh B, Kaur T, Singh S. Correction of raw disolution data for loss of drug during sampling. Indian J Pharm Sci. 1997; 59: 196-199.
18. Korsemeyer RW, Gurny R, Doelker E, Buri P, Peppas N. Mechanism of solute release from porous hydrophillic polymers. Int J Pharm. 1983; 15: 25-35. doi:10.1016/0378-5173(83)90064-9
19. Korsemeyer RW, Peppas N. Macromolecular and modelling aspects of swelling controlled systems. In: Roseman TJ, Mansdorf SJ (eds.). Controlled release delivery systems. New York: Marcel Dekker; 1983: 77-90.
20. Baumgartner S, Kristl JO, Vrecer F, Vodopivec P, Zorko B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm. 2000; 195: 125-135. doi:10.1016/S0378-5173(99)00378-6
21. Sangekar S, Vadino WA, Chaudry I, Parr A, Behin R, Digenis G. Evaluation of effect of food and specific gravity on tablets on gastric retention time. Int J Pharm. 1987; 35: 187-191. doi:10.1016/0378-5173(87)90129-3
22. Singh B, Gupta RK, Ahuja N. Computer assisted optimization of pharmaceutical formulations and processes (10th chapter). In: Jain NK.(ed.). Pharmaceutical product development. CBS publishers, New Delhi. 2006: 273-318.
23. Chary RB, Vani G, Rao YM. In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 1999; 25: 685-690. doi:10.1081/DDC-100102226
24. Smart JD, Kellaway IW, Worthington HE. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol. 1984; 36: 295-299. PMid:6145763
25. Mortazavi SA, Smart JD. An investigation of some factors influencing the in vitro assessment of mucoadhesion. Int J Pharm. 1995; 116: 223-230. doi:10.1016/0378-5173(94)00299-K
26. Singh B, Ahuja N. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm: 2002, 28: 431-442: doi:10.1081/DDC-120003004
27. Li S, Lin S, Daggy BP, Mirchandani HL; Chien YW. Effect of HPMC and Carbopol on the release and floating properties of Gastric Floating Drug Delivery System using factorial design. Int J Pharm: 2003, 253: 13-22. doi:10.1016/S0378-5173(02)00642-7
28. Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm. 2000; 26: 965-969. doi:10.1081/DDC-100101323
29. Prudat-Christiqens C, Arnaud P, Allain P, Chaumeil JC. Aminophylline bioadhesive tablets attempted by wet granulation. Int J Pharm. 1996; 141: 109-116. doi:10.1016/0378-5173(96)04622-4
30. Bolourchian N, Hadidi N, Foroutan SM, Shafaghi B. Development and optimization of a sublingual tablet formulation for physostigmine salicylate. Acta Pharm. 2009; 59: 301-312. doi:10.2478/v10007-009-0028-5
31. IP. Indian Pharmacopoeia. The Indian Pharmacopoeia Commission, Central Indian Pharmacopoeia Laboratory, Ministry of Health and Family Welfare, Govt. of India, Sector 23, Raj Nagar, Ghaziabad 201 002, India.; 2007.
32. BP. British Pharmacopoeia. British Pharmacopoeia Commission, Market Towers, 1 Nine Elms Lane, London SW8 5NQ. ISSN: 10:011-3227507, ISBN: 13:9780113227501. 2008.
33. Perez-Marcos B, Iglesias R, Gomez-amoza JL, Martinez-Pacheo R, Souto C, Conchiero R. Mechanical and drug release properties of atenolol-carbomer hydrophilic matrix tablets. J Control Rel. 1991; 17: 267-276. doi:10.1016/0168-3659(91)90145-4
34. Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm. 1988; 14: 283-318. doi:10.3109/03639048809151972
35. Gupta A, Garg S, Khar RK. Mucoadhesive buccal drug delivery systems: A review. Indian Drugs. 1992; 29: 585-588.
36. Timmermans J, Moes AJ. How well do floating dosage forms float? Int J Pharm. 1990; 62: 207-216. doi:10.1016/0378-5173(90)90234-U
37. Arza RA, Gonugunta CS, Veerareddy PR. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 2009; 10: 220-226. doi:10.1208/s12249-009-9200-y
38. Singh S, Singh J, Muthu MS, Balasubramaniam J, Mishra B. Gastroretentive drug delivery system of metoclopramide hydrochloride: formulation and in vitro evaluation. Curr Drug Deliv. 2007; 4: 269-275. doi:10.2174/156720107782151287
39. Jimenez-Martinez I, Quirino-Barreda T, Villafuerte-Robles L. Sustained delivery of captopril from floating matrix tablets. Int J Pharm. 2008; 362: 37-43. doi:10.1016/j.ijpharm.2008.05.040
40. Sauzet C, Claeys-Bruno M, Nicolas M, Kister J, Piccerelle P, Prinderre P. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. Int J Pharm. 2009; 378: 23-29. doi:10.1016/j.ijpharm.2009.05.027